VEXAS syndrome.

Saved in:
Bibliographic Details
Title: VEXAS syndrome.
Authors: Beck DB; Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY, USA. David.Beck@nyulangone.org.; Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA. David.Beck@nyulangone.org.; Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, USA. David.Beck@nyulangone.org., Georgin-Lavialle S; Sorbonne University, Internal Medicine Department, Tenon Hospital, DMU3ID, FHU INFLAMME, Assistance Publique-Hôpitaux de Paris, CEREMAIA reference centre, INSERM UMRS 1155, Paris, France., Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Patel BA; Hematology Branch, National Heart, Lung, and Blood Institutes, National Institutes of Health, Bethesda, MD, USA., Ferrari S; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy. Ferrari.samuele@hsr.it.; Vita-Salute San Raffaele University, Milan, Italy. Ferrari.samuele@hsr.it.
Source: Nature reviews. Disease primers [Nat Rev Dis Primers] 2026 Apr 16; Vol. 12 (1). Date of Electronic Publication: 2026 Apr 16.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101672103 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-676X (Electronic) Linking ISSN: 2056676X NLM ISO Abbreviation: Nat Rev Dis Primers Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2056-676X
DOI:10.1038/s41572-026-00695-w